An update on opsoclonus
- 1 February 2007
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Neurology
- Vol. 20 (1), 25-31
- https://doi.org/10.1097/wco.0b013e3280126b51
Abstract
The aim of this article is to review opsoclonus, with particular emphasis on its immunopathogenesis and pathophysiology. Infections (West Nile virus, Lyme disease), neoplasms (non-Hodgkin's lymphoma, renal adenocarcinoma), celiac disease, and allogeneic hematopoietic stem cell transplantation can cause opsoclonus. Newly identified autoantibodies include antineuroleukin, antigliadin, antiendomysial, and anti-CV2. Evidence suggests that the autoantigens of opsoclonus reside in postsynaptic density, or on the cell surface of neurons or neuroblastoma cells (where they exert antiproliferative and proapoptotic effects). Most patients, however, are seronegative for autoantibodies. Cell-mediated immunity may also play a role, with B and T-cell recruitment in the cerebrospinal fluid linked to neurological signs. Rituximab, an anti-CD20 monoclonal antibody, seems efficacious as an adjunctive therapy. Although changes in synaptic weighting of saccadic burst neuron circuits in the brainstem have been implicated, disinhibition of the fastigial nucleus in the cerebellum, or damage to afferent projections to the fastigial nucleus, is a more plausible pathophysiologic mechanism which is supported by functional magnetic resonance imaging findings in patients. There is increasing recognition that both humoral and cell mediated immune mechanisms are involved in the pathogenesis of opsoclonus. Further studies are needed to further elucidate its immunopathogenesis and pathophysiology in order to develop novel and efficacious therapy.Keywords
This publication has 103 references indexed in Scilit:
- Opsoclonus-myoclonus as a manifestation of Lyme diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Opsoclonus-Myoclonus Associated With Celiac DiseasePediatric Neurology, 2006
- Delayed, Recurrent Opsoclonus-Myoclonus Syndrome Responding to PlasmapheresisPediatric Neurology, 2005
- Sleep Disturbance and Rage Attacks in Opsoclonus-Myoclonus Syndrome: Response to TrazodoneThe Journal of Pediatrics, 2005
- Cerebrospinal Fluid ACTH and Cortisol in Opsoclonus-Myoclonus: Effect of TherapyPediatric Neurology, 2005
- Immunologic and Clinical Responses to Rituximab in a Child With Opsoclonus-Myoclonus SyndromePediatrics, 2005
- Benign opsoclonus in preterm infantsPediatric Neurology, 2004
- Metaiodobenzylguanidine total-body scintigraphy required for revealing occult neuroblastoma in opsoclonus-myoclonus syndromeEuropean Journal of Pediatrics, 2002
- Opsoclonus, a rare complication of cocaine misuse.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Opsoclonus induced by phenytoin and diazepamAnnals of Neurology, 1987